Rob Brandt

VELYS™ Robotic-Assisted Solution is designed to improve accuracy and precision of femoral and tibial implant alignment which will result in improved long-leg alignment compared to manual TKA. 7* During #NationalASCMonth, explore how the VELYS™ Robotic-Assisted Solution can be used for better patient outcomes and cost-savings in the ASC setting. Learn more: http://bit.ly/44VeXv6

١٨٧

In today’s What’s New at Arthrex, Brian Cole, MD, demonstrates a CuffMend™ rotator cuff augmentation procedure. He uses the FiberStitch™ RC 1.5 for secure medial fixation of an ArthroFlex dermal allograft, and self punching PushLock® anchors for simple lateral fixation. ArthroFLEX® is a trademark of LifeNet Health. Learn more: https://lnkd.in/eySjxdqx

٣٥٥

٥ تعليق

Amputation patients have high rates of post- surgical pain, with 60% of amputees experiencing Residual Limb Pain and up to 85% reporting Phantom Limb Pain. Until now, patients had limited relief and few non-opioid alternatives. ​ Introducing the cryoXT™ probe. Harnessing proven cryoICE technology at the time of surgery, this latest advancement fits naturally into the procedure and adds only minutes. ​ Discover the advancement taking on post-amputation pain: https://okt.to/aQ8O9G #cryoNB #AmputationPain

١٢٥

٢ تعليق

Independent studies confirm there is no significant difference between triclosan-coated sutures and non-coated sutures on SSI rates.²𝄒‡ Learn more: https://lnkd.in/enfsfdDr Product usage represented may not be approved or cleared in all markets.

٩٠

✅ Advanced steering control can translate into more consistent outcomes for #LAAC procedures. The WATCHMAN TruSteer™ Access System helped achieve an outstanding 99.3% implant success rate of the WATCHMAN FLX™ Pro LAAC Device in the HEAL-LAA study, representing an 86% reduction in case aborts compared to fixed curve sheaths. WATCHMAN TruSteer also provided favorable device seal through 45 days in more complex, multi-lobed anatomies, giving physicians greater confidence and more options to treat a broader range of patients. View the library of WATCHMAN™ Device Platform clinical evidence: qrco.de/bgEXQG #NYValves2025 #NYValves #LAACSummit WATCHMAN FLX Pro Left Atrial Appendage Closure Device Indications, Safety, and Warnings: https://qrco.de/bg3esL WATCHMAN TruSteer Access System Indications, Safety, and Warnings: https://qrco.de/bg3euD

١٦٨

Major milestone for pelvic fracture treatment! CMS has approved a New Technology Add-on Payment (NTAP) for the iFuse TORQ TNT™ Implant System, effective October 1, 2025. This designation provides up to $4,136 in additional inpatient reimbursement, supporting hospital adoption of this innovative device for pelvic fracture treatment. Why it matters: The iFuse TORQ TNT is the 1st 3D-printed, porous, threaded implant with lengths capable of spanning the posterior pelvis: • ✅ 1.5x stronger in bending vs. 7.3 mm stainless steel cannulated screw1 • ✅ 3.5x greater insertional torque vs. 7.3 mm stainless steel screw2 • ✅ 5.7x greater removal torque at 6 weeks in vivo vs. 7.3 mm stainless steel screw3 • ✅ First transiliac–transsacral length implant with accompanying navigation instrumentation4 With NTAP approval, hospitals can offer this breakthrough treatment with additional CMS reimbursement support, subject to criteria. 📩 Need help preparing for coding and implementation? The SI-BONE Reimbursement Management Team is here to support your teams with education as hospitals prepare for coding and implementation. Connect with us: https://lnkd.in/gB_UkkUG #PelvicTrauma #Orthopedics #Reimbursement #NTAP #iFuseTNT #FragilityFractures #SIBONE #TraumaInnovation 1. 301122-TS-A. Mechanical data, including computational modeling, is not necessarily indicative of human clinical outcomes. 2. 301401-TS Results from animal testing are not necessarily indicative of human clinical outcomes. Larger 8.7 mm diameter than a 7.3 mm cannulated stainless-steel screw also contributes to increased insertional torque 3. 301437-TS Results from animal testing are not necessarily indicative of human clinical outcomes. 4. Data on file. DISCLAIMER: This post is for informational purposes only and is not legal advice or official guidance from payors. It is not intended to increase or maximize reimbursement by any payor. Hospitals and physicians are solely responsible for being in compliance with Medicare and other payor rules and requirements for the information submitted with all claims and appeals. SI-BONE does not warrant or guarantee that the use of this information will result in coverage or payment for SI joint fusion. Before any claims or appeals are submitted, hospitals and physicians should review official payor instructions and requirements, should confirm the accuracy of their coding or billing practices with these payors and should use independent judgment when selecting codes that most appropriately describe the services or supplies provided to a patient. Indications and Instructions for Use at https://si-bone.com/label.

٦٨